medical research

cholesterol

Cholesterol meds may reduce liver cancer risk by 31%

A recent breakthrough study has uncovered a promising link between non-statin cholesterol-lowering medications and liver cancer prevention. Among the drugs examined, ezetimibe—commonly known by its

New cancer risks shock millennials and Gen X

A study published in The Lancet Public Health has revealed a disturbing trend affecting younger generations. Analysis of data from over 23 million cancer patients

fiber

Tips on how to slow your aging through dieting

Recent research from UC San Francisco has revealed how dietary choices—specifically sugar consumption and antioxidant-rich diets—can significantly affect biological aging, shedding light on their profound

antidepressants

Aspirin’s surprising impact on cancer risk

Recent research from Massachusetts General Hospital and Harvard Medical School has uncovered aspirin‘s surprising protective effect against colorectal cancer, particularly among individuals with less healthy

rapamycin

What to expect from rapamycin for fertility

Recent groundbreaking research has unveiled the potential of rapamycin, a drug commonly used in transplant medicine, to delay ovarian aging and extend women’s reproductive years.

hypertension

A single pill changing hypertension forever

A groundbreaking development in hypertension treatment has emerged from the University of South Wales, offering new hope for the 1.28 billion adults worldwide affected by

systolic

The hidden heart risk you’re not hearing about

A groundbreaking discovery from the Cardiovascular Research Center in Spain has revealed that mutations in blood stem cells, which had been previously overlooked, may play

extended phone calls

What extended phone calls do to your heart

A groundbreaking analysis conducted using the UK Biobank dataset, encompassing 444,027 participants, has provided compelling evidence about the impact of phone call duration on cardiovascular